Literature DB >> 29736305

RNA activation technique and its applications in cancer research.

Xiao-Yu Wang1, Long Yuan1, Yan-Ling Li1, Si-Jie Gan1, Lin Ren1, Fan Zhang1, Jun Jiang1, Xiao-Wei Qi1.   

Abstract

RNA activation (RNAa) is a mechanism of gene activation mediated by small activating RNAs. The activation of gene expression by small activating RNA has excellent targeting specificity and flexibility, with a persistent and strong effect. Studies have shown that the RNAa technique has broad prospects for application in the research on tumor pathogenesis and the treatment of tumors. This paper reviews the literature on RNAa with regard to the course of discovery, the mechanisms and characteristics of action, and the current status and prospects of application.

Entities:  

Keywords:  RNA activation; cancer; small activating RNA

Year:  2018        PMID: 29736305      PMCID: PMC5934550     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  65 in total

1.  Prostate-specific and androgen-dependent expression of a novel homeobox gene.

Authors:  C J Bieberich; K Fujita; W W He; G Jay
Journal:  J Biol Chem       Date:  1996-12-13       Impact factor: 5.157

2.  Gene regulation for higher cells: a theory.

Authors:  R J Britten; E H Davidson
Journal:  Science       Date:  1969-07-25       Impact factor: 47.728

Review 3.  A clinical overview of WT1 gene mutations.

Authors:  M Little; C Wells
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

4.  Reduction of wild type p53 function confers a hormone resistant phenotype on LNCaP prostate cancer cells.

Authors:  M Burchardt; T Burchardt; A Shabsigh; M Ghafar; M W Chen; A Anastasiadis; A de la Taille; A Kiss; R Buttyan
Journal:  Prostate       Date:  2001-09-15       Impact factor: 4.104

5.  Double strand RNA-guided endogeneous E-cadherin up-regulation induces the apoptosis and inhibits proliferation of breast carcinoma cells in vitro and in vivo.

Authors:  Wei Junxia; Gao Ping; Han Yuan; Zhang Lijun; Ren Jihong; Lin Fang; Long Min; Wang Xi; He Ting; Dong Ke; Zhang Huizhong
Journal:  Cancer Sci       Date:  2010-04-21       Impact factor: 6.716

Review 6.  Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene.

Authors:  Vicki Huff
Journal:  Nat Rev Cancer       Date:  2011-01-20       Impact factor: 60.716

7.  Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo.

Authors:  Vikash Reebye; Pål Sætrom; Paul J Mintz; Kai-Wen Huang; Piotr Swiderski; Ling Peng; Cheng Liu; Xiaoxuan Liu; Steen Lindkaer-Jensen; Dimitris Zacharoulis; Nikolaos Kostomitsopoulos; Noriyuki Kasahara; Joanna P Nicholls; Long R Jiao; Madhava Pai; Duncan R Spalding; Malkhaz Mizandari; Tinatin Chikovani; Mohamed M Emara; Abdelali Haoudi; Donald A Tomalia; John J Rossi; Nagy A Habib
Journal:  Hepatology       Date:  2013-12-09       Impact factor: 17.425

8.  Up-regulation of E-cadherin by small activating RNA inhibits cell invasion and migration in 5637 human bladder cancer cells.

Authors:  Qiqi Mao; Yubing Li; Xiangyi Zheng; Kai Yang; Huafeng Shen; Jie Qin; Yu Bai; Debo Kong; Xiaolong Jia; Liping Xie
Journal:  Biochem Biophys Res Commun       Date:  2008-08-24       Impact factor: 3.575

Review 9.  The many facets of the Wilms' tumour gene, WT1.

Authors:  Peter Hohenstein; Nicholas D Hastie
Journal:  Hum Mol Genet       Date:  2006-10-15       Impact factor: 6.150

10.  Small RNA and its application in andrology and urology.

Authors:  Ji Wang; Long-Cheng Li
Journal:  Transl Androl Urol       Date:  2012
View more
  2 in total

1.  Preparation of a miR-155-activating nucleic acid nanoflower to study the molecular mechanism of miR-155 in inflammation.

Authors:  Wenxin Wang; Jie Geng; Xiaohan Wu; Jianguang Zhang; Chenna Zheng; Huachun Rao; Tianyu Li; Yong Diao; Huiyong Yang
Journal:  Mol Med       Date:  2022-06-17       Impact factor: 6.376

Review 2.  Natural antisense transcripts as drug targets.

Authors:  Olga Khorkova; Jack Stahl; Aswathy Joji; Claude-Henry Volmar; Zane Zeier; Claes Wahlestedt
Journal:  Front Mol Biosci       Date:  2022-09-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.